Skip to main content
. 2023 Jul 25;63(9):400–408. doi: 10.2176/jns-nmc.2022-0354

Table 2.

Baseline characteristics of the study groups

Baseline characteristics group A
(n = 4)
group B
(n = 6)
group C
(n = 26)
P value
Age (mean ± SD), years 68.5 ± 7.6 56.7 ± 13.0 61.3 ± 14.7 0.54
Male, n (%) 1 (25.0) 3 (50.0) 14 (53.8) 0.8
Side (left), n (%) 3 (75.0) 3 (50.0) 7 (26.9) 0.39
Duration of symptoms (mean ± SD), months 96.8 ± 93.7 56.0 ± 40.2 73.0 ± 78.2 0.82
Risk factors, n (%)
Hypertension 0 (0) 0 (0) 9 (34.6) 0.36
Dyslipidemia 0 (0) 0 (0) 2 (7.7) 0.8
Cerebrovascular disease 1 (25.0) 0 (0) 2 (7.7) 0.93
Nerve block 1 (25.0) 1 (12.5) 3 (11.5) 0.92
Gamma knife 1 (25.0) 0 (3.8) 1 (3.8) 0.8
Offending vessels, n (%)
SCA 1 (25.0) 5 (83.3) 22 (84.6) 0.13
TCA 2 (50.0) 0 (0) 7 (26.9) 0.54
AICA 3 (75.0) 2 (33.3) 8 (30.8) 0.49
VA, BA 0 (0) 0 (0) 3 (11.5) 0.93
Vein 1 (25.0) 4 (66.7) 14 (53.8) 0.8

Baseline data did not differ between the three groups. SD, standard deviation; SCA, superior cerebellar artery; TCA, trigeminal cerebellar artery; AICA, anterior inferior cerebellar artery; VA, vertebral artery; BA, basilar artery